| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,661 |
22,635 |
$9.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,954 |
7,476 |
$1.96M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,016 |
9,422 |
$1.67M |
| G0378 |
Hospital observation service, per hour |
2,762 |
2,100 |
$991K |
| 36415 |
Collection of venous blood by venipuncture |
21,033 |
17,926 |
$493K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,181 |
839 |
$401K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,175 |
2,799 |
$281K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,148 |
1,745 |
$243K |
| 90791 |
Psychiatric diagnostic evaluation |
1,661 |
1,513 |
$162K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,900 |
1,732 |
$141K |
| 97602 |
|
1,117 |
810 |
$126K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,025 |
997 |
$126K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,612 |
5,729 |
$107K |
| 80053 |
Comprehensive metabolic panel |
12,043 |
10,904 |
$88K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,925 |
4,528 |
$69K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
547 |
423 |
$68K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,725 |
3,595 |
$68K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
594 |
574 |
$50K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,227 |
1,094 |
$46K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,809 |
1,088 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,648 |
25,999 |
$37K |
| 70450 |
Computed tomography, head or brain; without contrast material |
361 |
322 |
$30K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
112 |
112 |
$27K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
230 |
225 |
$26K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
323 |
281 |
$26K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
757 |
686 |
$25K |
| 71046 |
Radiologic examination, chest; 2 views |
1,166 |
1,002 |
$24K |
| 99220 |
|
176 |
171 |
$21K |
| J3490 |
Unclassified drugs |
185 |
135 |
$16K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
520 |
431 |
$15K |
| 81001 |
|
2,371 |
2,097 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,043 |
935 |
$12K |
| A9270 |
Non-covered item or service |
4,564 |
1,411 |
$11K |
| 84484 |
|
2,596 |
1,859 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
145 |
135 |
$9K |
| 17250 |
|
79 |
78 |
$9K |
| 99217 |
|
181 |
175 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
971 |
886 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
260 |
230 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
48 |
40 |
$7K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
142 |
36 |
$7K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,782 |
1,884 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
19 |
17 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,531 |
2,882 |
$5K |
| 82962 |
|
307 |
108 |
$4K |
| 88307 |
|
86 |
64 |
$4K |
| 99225 |
|
76 |
51 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
73 |
65 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
14 |
$2K |
| 85610 |
|
399 |
279 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,473 |
1,261 |
$2K |
| 85027 |
|
532 |
388 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
24 |
24 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
64 |
61 |
$1K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
59 |
57 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,248 |
923 |
$795.65 |
| 83690 |
|
645 |
588 |
$781.04 |
| 83880 |
|
15 |
14 |
$739.96 |
| 96376 |
|
42 |
26 |
$731.26 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
735 |
544 |
$664.94 |
| 83605 |
|
104 |
78 |
$516.52 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
44 |
27 |
$482.12 |
| 97803 |
|
16 |
13 |
$340.37 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
50 |
43 |
$260.77 |
| 83735 |
|
118 |
88 |
$189.55 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
508 |
356 |
$159.85 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
146 |
87 |
$150.84 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
13 |
12 |
$139.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
519 |
393 |
$135.55 |
| 82077 |
|
41 |
37 |
$109.89 |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
27 |
$72.38 |
| J2704 |
Injection, propofol, 10 mg |
227 |
162 |
$67.98 |
| 81025 |
|
48 |
39 |
$54.27 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
15 |
$21.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
45 |
41 |
$5.66 |
| A6022 |
Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each |
13 |
12 |
$0.00 |
| 84703 |
|
12 |
12 |
$0.00 |
| 87081 |
|
15 |
15 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19 |
12 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
19 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17 |
17 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
18 |
18 |
$0.00 |